238 related articles for article (PubMed ID: 29044225)
1. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A
Pierdomenico AM; Patruno S; Codagnone M; Simiele F; Mari VC; Plebani R; Recchiuti A; Romano M
Sci Rep; 2017 Oct; 7(1):13519. PubMed ID: 29044225
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
Pierdomenico AM; Recchiuti A; Simiele F; Codagnone M; Mari VC; Davì G; Romano M
J Biol Chem; 2015 Feb; 290(6):3592-600. PubMed ID: 25505240
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa.
Higgins G; Fustero Torre C; Tyrrell J; McNally P; Harvey BJ; Urbach V
Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1053-61. PubMed ID: 27084849
[TBL] [Abstract][Full Text] [Related]
4. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
Higgins G; Buchanan P; Perriere M; Al-Alawi M; Costello RW; Verriere V; McNally P; Harvey BJ; Urbach V
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):178-90. PubMed ID: 24588705
[TBL] [Abstract][Full Text] [Related]
5. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A
Gaudin A; Tolar M; Peters OA
Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the formyl peptide receptor 2 gene.
Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
Buchanan PJ; McNally P; Harvey BJ; Urbach V
Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L193-201. PubMed ID: 23686859
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.
Waechter V; Schmid M; Herova M; Weber A; Günther V; Marti-Jaun J; Wüst S; Rösinger M; Gemperle C; Hersberger M
J Immunol; 2012 Feb; 188(4):1856-67. PubMed ID: 22246625
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.
Simiele F; Recchiuti A; Mattoscio D; De Luca A; Cianci E; Franchi S; Gatta V; Parolari A; Werba JP; Camera M; Favaloro B; Romano M
FASEB J; 2012 Mar; 26(3):1323-33. PubMed ID: 22131270
[TBL] [Abstract][Full Text] [Related]
11. Hemin impairs resolution of inflammation via microRNA-144-3p-dependent downregulation of ALX/FPR2.
Sun G; Lu Y; Zhao L; Xia W; Zhang H; Wang L; Zhang L; Wen A
Transfusion; 2019 Jan; 59(1):196-206. PubMed ID: 30499593
[TBL] [Abstract][Full Text] [Related]
12. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
[TBL] [Abstract][Full Text] [Related]
13. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.
Petri MH; Laguna-Fernández A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Bäck M
Cardiovasc Res; 2015 Jan; 105(1):65-74. PubMed ID: 25341894
[TBL] [Abstract][Full Text] [Related]
14. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.
Verrière V; Higgins G; Al-Alawi M; Costello RW; McNally P; Chiron R; Harvey BJ; Urbach V
PLoS One; 2012; 7(5):e37746. PubMed ID: 22662206
[TBL] [Abstract][Full Text] [Related]
16. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of monocytic expression of leukotriene and lipoxin receptors.
Petri MH; Thul S; Ovchinnikova O; Bäck M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):138-43. PubMed ID: 26248046
[TBL] [Abstract][Full Text] [Related]
18. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
Rabiet MJ; Macari L; Dahlgren C; Boulay F
J Biol Chem; 2011 Jul; 286(30):26718-31. PubMed ID: 21543323
[TBL] [Abstract][Full Text] [Related]
19. Effects of the ALX/FPR2 receptors of lipoxin A
Gan N; Zhang R; Xu X; Wang Y; Qi A; Zhang Y; Wang A
Biomed Pharmacother; 2019 Apr; 112():108595. PubMed ID: 30784911
[TBL] [Abstract][Full Text] [Related]
20. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
